Related Experiment Videos
Selectins in the HIT syndrome: pathophysiologic role and therapeutic modulation
J Fareed1, J M Walenga, D A Hoppensteadt
1Department of Pathology, Cardiovascular Institute, Loyola University Chicago, Maywood, Illinois, USA.
Seminars in Thrombosis and Hemostasis
|June 5, 1999
Summary
Heparin-induced thrombocytopenia (HIT) involves complex cell activation. This study measured soluble selectins in HIT patients, finding elevated levels that may indicate disease severity and guide treatment.
Area of Science:
- Hematology
- Immunology
- Vascular Biology
Background:
- Heparin-induced thrombocytopenia (HIT) is a complex immune-mediated condition affecting platelets, endothelium, and leukocytes.
- HIT pathophysiology involves coagulation activation and fibrinolytic deficits, with known markers of hemostatic activation.
- Circulating levels of soluble selectins (P-, E-, and L-selectins) in HIT have not been previously reported.
Purpose of the Study:
- To investigate the circulating levels of soluble P-, E-, and L-selectins in patients with HIT.
- To assess the modulation of these soluble selectins following therapeutic intervention for HIT.
- To explore the potential of soluble selectins as an index of HIT pathophysiology.
Main Methods:
- Utilized highly sensitive enzyme-linked immunosorbent assays (ELISAs) to quantify soluble P-, E-, and L-selectins.
- Measured circulating levels of these adhesion molecules in patients diagnosed with HIT.
- Monitored changes in soluble selectin levels after therapeutic interventions, including the use of recombinant hirudin.
Main Results:
- This study reports the circulating levels of soluble P-, E-, and L-selectins in HIT patients for the first time.
- Observed alterations in these soluble selectin levels during acute phases of HIT syndromes.
- Documented the modulation of soluble selectin levels after therapeutic interventions in HIT patients.
Conclusions:
- Elevated circulating levels of soluble P-, E-, and L-selectins are associated with the pathophysiology of HIT.
- These soluble selectins may serve as valuable biomarkers for assessing HIT activity and severity.
- Further research into adjunct therapies may be necessary to address the immunoactivation of cells in HIT, beyond anticoagulation.